Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Dalfampridine
(D04127)
[1] Dalfampridine[1] Dalfampridine (D04127) 💬[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬
[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[2] 4, 13 💬
2Dalfampridine ER
(D04127)
[1] Dalfampridine[1] Dalfampridine (D04127) 💬[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬
[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬
3Dalfampridine ER, 10 Mg Oral Tablet, Extended Release
(D04127)
[1] Dalfampridine[1] Dalfampridine (D04127) 💬[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬
[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬
4Dalfampridine-ER 10mg
(D04127)
[1] Dalfampridine[1] Dalfampridine (D04127) 💬[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬
[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬
5Dalfampridine-ER 5mg
(D04127)
[1] Dalfampridine[1] Dalfampridine (D04127) 💬[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬
[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬
6Sustained-release oral dalfampridine
(D04127)
[1] Dalfampridine[1] Dalfampridine (D04127) 💬[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬
[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬